Canada Spends Logo

Explorez notre analyse du budget 2026

Grant: Doctoral Award - Frederick Banting and Charles Best Canada Graduate Scholarships

McMaster University

$105,000.00

Obesity and prediabetes impact outcomes of enteric infection

EF 2015-16

Résumé
Almost half of all Canadians are obese or overweight. This is a growing national health problem that includes large financial burden for the healthcare system. Diet, including eating to much fat is a key contributor to obesity-driven metabolic diseases such as type II diabetes. It is clear that metabolism and the immune system are closely associated. The complications of obesity extend to how the immune system can fight off infectious diseases. Obesity causes activation of the immune system, which is seen as a chronic low-level inflammation. This type of chronic inflammation during obesity actually stops the immune system from recognizing bacterial infections. This can lead to increased infectious disease during obesity and we need to understand how obesity impacts an individual's ability to contract and combat a bacterial infection. The gut is a common site of infection. Importantly, the gut is the site where the food we eat and bacteria that normally live in us come into direct contact with bacteria that cause infection. We have made the surprising discovery that obesity decreases the ability to get rid of a gut infection. We also discovered that obesity and diabetes are very different since diabetes decreased survival from gut infection. This research has the potential to improve the health of Canadians by restoring immune responses to infectious bacteria during obesity, and diabetes. The altered immune responses during obesity and diabetes may be potent drug targets to improve a patient's susceptibility to infection, resulting in a reduction in complications for overweight, obese and diabetic Canadians.
Programme
Doctoral Award - Frederick Banting and Charles Best Canada Graduate Scholarships
Bénéficiaire
Emplacement
Ontario, Canada
Type de bénéficiaire
Academia
Type
Grant
Source
CIHR Funding Decisions Database

Tel que publié

Id
348004
Name
Lau Trevor C
Region
Ontario
Country
Canada
Orgtype
Institution Paid; Research Institution
Instname2
Nutrition, Metabolism and Diabetes
Theme2
Biomedical
Prcname2
Doctoral Research Awards - A
Projecttitle
Obesity and prediabetes impact outcomes of enteric infection
Programtype2
Studentship Programs
Orgnameinp2
McMaster University
Cihramount2
$105,000
Cihrequipment2
$0
Programname2
Doctoral Award - Frederick Banting and Charles Best Canada Graduate Scholarships
Keyworddelim
Animal Models Of Metabolic Syndrome; Diabetes Mellitus; Endocrinology; Enteric Infection; Inflammation; Obesity
Abstract
Almost half of all Canadians are obese or overweight. This is a growing national health problem that includes large financial burden for the healthcare system. Diet, including eating to much fat is a key contributor to obesity-driven metabolic diseases such as type II diabetes. It is clear that metabolism and the immune system are closely associated. The complications of obesity extend to how the immune system can fight off infectious diseases. Obesity causes activation of the immune system, which is seen as a chronic low-level inflammation. This type of chronic inflammation during obesity actually stops the immune system from recognizing bacterial infections. This can lead to increased infectious disease during obesity and we need to understand how obesity impacts an individual's ability to contract and combat a bacterial infection. The gut is a common site of infection. Importantly, the gut is the site where the food we eat and bacteria that normally live in us come into direct contact with bacteria that cause infection. We have made the surprising discovery that obesity decreases the ability to get rid of a gut infection. We also discovered that obesity and diabetes are very different since diabetes decreased survival from gut infection. This research has the potential to improve the health of Canadians by restoring immune responses to infectious bacteria during obesity, and diabetes. The altered immune responses during obesity and diabetes may be potent drug targets to improve a patient's susceptibility to infection, resulting in a reduction in complications for overweight, obese and diabetic Canadians.
Competitiondate
201510
Approvedterm2
3 yrs 0 mth
Pinamesdelim
Lau, Trevor C
Approvedterm
3 ans 0 mois
Cihrcontribution2
~ $105,000~ $0~